Bertozzi research advances medicine
Bertozzi’s chemistry expertise advances research into cancer immunotherapies, tumor biology and COVID-19.
Magazine explores molecules within us
The new issue of Stanford Medicine magazine features articles about the molecules that make us who we are and how understanding them can lead to medical discoveries and innovations.
Therapeutics accelerator launched
Deerfield Management, a health care investment firm, has committed up to $130 million to support innovative translational research at Stanford.
Drug Discovery Symposium runs April 19-20
The annual conference will feature an interdisciplinary cast of researchers, industry leaders and policymakers who will discuss advances in therapeutics, including COVID-19 treatments.
Biochemist Robert Baldwin dies at 93
Baldwin propelled leaps in scientists’ understanding of how proteins assemble themselves into the three-dimensional shapes that are essential to their function.
High-risk, high-reward grants for researchers
Annelise Barron, Peter Kim, Siddhartha Jaiswal and Keren Haroush will receive grants totaling $10 million to fund their investigations. The awards support risky efforts that could potentially have a big impact in the biomedical sciences.
Biochemist Dale Kaiser dies
Using a virus as an experimental system, Kaiser made fundamental discoveries that were instrumental in ushering in the era of recombinant DNA technology, often known as gene splicing.
Scrambled eggs self-organize
The cytoplasm of ruptured frog eggs can self-organize into cell-like compartments that retain the ability to undergo divisions.
New incubator for life science innovation
A recently vacated building in Stanford Research Park will be the future home of a new life science incubator and lab suites. Located near campus, this incubator will serve as an anchor for a preeminent life science district.
Helping with NASA twins study
Stanford scientists and their collaborators found markers of immune-related stress and other molecular changes in the body of NASA astronaut Scott Kelly.
Mechanism underlying ‘workaholic’ heart
A study led by Stanford Medicine researchers shows why so many mutations associated with hypertrophic cardiomyopathy, a heart disorder, alter a key constituent of muscle cells in a way that makes it work overtime.
- Big Data
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- Developmental Biology
- Global Health
- Health Policy
- Infectious Disease
- Mental Health
- Patient Care
- Precision Health
- Preventive Medicine
- Stem Cells
- Women's Health